Human Honarpisheh
Research Subjects
Human Honarpisheh has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Jonas Herzberg
Department of Surgery, Krankenhaus Reinbek St. Adolf-Stift, 21465 Reinbek, Germany
4 shared publications - Salman Yousuf Guraya
Gulf Medical University College of Medicine
4 shared publications - Tim Strate
Department of Surgery, Krankenhaus Reinbek St. Adolf-Stift, 21465 Reinbek, Germany
4 shared publications - Ann-Kristin Becker
Abteilung für Psychiatrie und Psychotherapie, Asklepios Klinik Harburg, 21075 Hamburg, Germany
2 shared publications - Bastian Fischer
Affiliation Herz- und Diabeteszentrum NRW, Institut für Laboratoriums- und Transfusionsmedizin, Bad Oeynhausen, Germany
2 shared publications - Cornelius Knabbe
Ruhr University Bochum, Heart and Diabetes Center NRW, Institute of Laboratory and Transfusion Medicine, 32545 Bad Oeynhausen, Germany
2 shared publications
Latest Publications
- Open Access
Surgical Outcomes of Hybrid-Robotic Compared with Non-Robotic Oncological Esophagectomy for Adenocarcinoma Using a Fail-Safe Protocol—A Cohort Study
Background: Ivor Lewis esophagectomy for esophageal malignancies is a core element of the treatment but still comes with substantial postoperative complications. Especially within the learning curve of robotic esophagectomy, an optimal treatment pathway is crucial to minimize the clinical impact of this phase. This study aimed to compare the surgical outcomes of hybrid-robotic esophagectomy for adenocarcinoma of the esophagus with non-robotic procedures using a fail-safe protocol. Methods: This retrospective single-center study evaluated the outcome of hybrid-robotic procedures within the early robotic learning curve in comparison to a historical control group of laparoscopic and open non-robotic procedures using uni- and multivariable regression analysis. CUSUM analysis was applied for learning curve outcomes. All procedures were performed between January 2016 and December 2025 within a standardized fail-safe approach. The primary end point was the occurrence of anastomotic leakage (AL), whereas the overall complications as well as the number of harvested lymph nodes were secondary end points. Results: A total of 156 patients were analyzed, including 50 hybrid-robotic and 106 non-robotic resections. Robotic surgery was associated with a higher lymph node yield (40.9 ± 11.0 vs. 35.7 ± 13.1; p = 0.011) and a lower lymph node ratio (0.085 vs. 0.125; p = 0.046). The AL rate was 4.0% in the robotic group and 5.7% in the non-robotic group. Length of stay was significantly shorter after robotic procedures (13.1 ± 5.5 vs. 18.6 ± 11.3 days; p < 0.001). Conclusions: Establishing a robotic esophagectomy program within an established structured fail-safe protocol was not associated with an increased risk of anastomotic leakage or major complications. Within this standardized setting, an increased lymph node yield, potentially optimizing oncological quality was observed. These findings indicate that acceptable preoperative safety and oncological outcomes can be achieved even during the learning curve of hybrid-robotic esophagectomy embedded in a structured fail-safe protocol.
Open AccessSurgical Outcomes of Hybrid-Robotic Compared with Non-Robotic Oncological Esophagectomy for Adenocarcinoma Using a Fail-Safe Protocol—A Cohort Study
Background: Ivor Lewis esophagectomy for esophageal malignancies is a core element of the treatment but still comes with substantial postoperative complications. Especially within the learning curve of robotic esophagectomy, an optimal treatment pathway is crucial to minimize the clinical impact of this phase. This study aimed to compare the surgical outcomes of hybrid-robotic esophagectomy for adenocarcinoma of the esophagus with non-robotic procedures using a fail-safe protocol. Methods: This retrospective single-center study evaluated the outcome of hybrid-robotic procedures within the early robotic learning curve in comparison to a historical control group of laparoscopic and open non-robotic procedures using uni- and multivariable regression analysis. CUSUM analysis was applied for learning curve outcomes. All procedures were performed between January 2016 and December 2025 within a standardized fail-safe approach. The primary end point was the occurrence of anastomotic leakage (AL), whereas the overall complications as well as the number of harvested lymph nodes were secondary end points. Results: A total of 156 patients were analyzed, including 50 hybrid-robotic and 106 non-robotic resections. Robotic surgery was associated with a higher lymph node yield (40.9 ± 11.0 vs. 35.7 ± 13.1; p = 0.011) and a lower lymph node ratio (0.085 vs. 0.125; p = 0.046). The AL rate was 4.0% in the robotic group and 5.7% in the non-robotic group. Length of stay was significantly shorter after robotic procedures (13.1 ± 5.5 vs. 18.6 ± 11.3 days; p < 0.001). Conclusions: Establishing a robotic esophagectomy program within an established structured fail-safe protocol was not associated with an increased risk of anastomotic leakage or major complications. Within this standardized setting, an increased lymph node yield, potentially optimizing oncological quality was observed. These findings indicate that acceptable preoperative safety and oncological outcomes can be achieved even during the learning curve of hybrid-robotic esophagectomy embedded in a structured fail-safe protocol.
- Open Access
Effect of Preoperative Body Composition on Postoperative Anastomotic Leakage in Oncological Ivor Lewis Esophagectomy—A Retrospective Cohort Study
Background: Surgery for esophageal cancer has an associated high rate of postoperative complications such as anastomotic leakage (AL) and fistulas. Pre-operative sarcopenia as a loss of skeletal muscle mass and function is identified as a potential prognostic factor in determining the outcomes of oncological surgical resections for esophageal cancers. In this study, we evaluated the impact of body composition on postoperative complications in esophageal cancer surgery. Methods: In this cohort study, we analyzed patients’ body composition at the level of the third lumbar vertebra on CT scans before Ivor Lewis resections for esophageal cancers between January 2015 and December 2022. Patients with a skeletal muscle index (SMI) ≤ 38.5 cm2/m2 in women and ≤52.4 cm2/m2 in men were classified as sarcopenic. Postoperative complications were categorized following the Dindo–Clavien classification and included AL, postoperative pneumonia, length of hospital stay, and failure-to-rescue which were compared between the sarcopenic and non-sarcopenic patients. Results: From a group of 111 patients with Ivor Lewis esophagectomy, 70 patients (63.1%) were classified as sarcopenic based on the SMI and the previously published gender-specific cut-off values. AL occurred at 12.6% (5.6% in adenocarcinoma). Within the whole cohort, patients with AL had a significantly low SMI of 43.487 ± 8.088 vs. 48.668 ± 7.514; p = 0.012. Additionally, the SMI showed a negative correlation to the length of postoperative hospital stay (r = −0.204; p = 0.032; N = 111). The failure-to-rescue rate was higher in the group of sarcopenic patients (12.8% vs. 8%). Conclusions: Our data showed a correlation between SMI and AL. This effect could not be seen in gender-specific SMI. This study showed a lower failure-to-rescue rate in non-sarcopenic patients after Ivor Lewis esophagectomy. These findings underscore the crucial role of determining the preoperative nutritional and body composition status as measured by the preoperative CT scans.
Open AccessEffect of Preoperative Body Composition on Postoperative Anastomotic Leakage in Oncological Ivor Lewis Esophagectomy—A Retrospective Cohort Study
Background: Surgery for esophageal cancer has an associated high rate of postoperative complications such as anastomotic leakage (AL) and fistulas. Pre-operative sarcopenia as a loss of skeletal muscle mass and function is identified as a potential prognostic factor in determining the outcomes of oncological surgical resections for esophageal cancers. In this study, we evaluated the impact of body composition on postoperative complications in esophageal cancer surgery. Methods: In this cohort study, we analyzed patients’ body composition at the level of the third lumbar vertebra on CT scans before Ivor Lewis resections for esophageal cancers between January 2015 and December 2022. Patients with a skeletal muscle index (SMI) ≤ 38.5 cm2/m2 in women and ≤52.4 cm2/m2 in men were classified as sarcopenic. Postoperative complications were categorized following the Dindo–Clavien classification and included AL, postoperative pneumonia, length of hospital stay, and failure-to-rescue which were compared between the sarcopenic and non-sarcopenic patients. Results: From a group of 111 patients with Ivor Lewis esophagectomy, 70 patients (63.1%) were classified as sarcopenic based on the SMI and the previously published gender-specific cut-off values. AL occurred at 12.6% (5.6% in adenocarcinoma). Within the whole cohort, patients with AL had a significantly low SMI of 43.487 ± 8.088 vs. 48.668 ± 7.514; p = 0.012. Additionally, the SMI showed a negative correlation to the length of postoperative hospital stay (r = −0.204; p = 0.032; N = 111). The failure-to-rescue rate was higher in the group of sarcopenic patients (12.8% vs. 8%). Conclusions: Our data showed a correlation between SMI and AL. This effect could not be seen in gender-specific SMI. This study showed a lower failure-to-rescue rate in non-sarcopenic patients after Ivor Lewis esophagectomy. These findings underscore the crucial role of determining the preoperative nutritional and body composition status as measured by the preoperative CT scans.
- Open Access
Short-Term Drop in Antibody Titer after the Third Dose of SARS-CoV-2 BNT162b2 Vaccine in Adults
Little is known about the longevity of antibodies after a third dose of the mRNA-based SARS-CoV-2 vaccine BNT162b2 (BioNTech/Pfizer, Mainz, Germany). Therefore, serum antibody levels were evaluated after a third dose of BNT162b2 in healthy adult healthcare workers in Germany. These antibody levels dropped significantly within a short period of 11 weeks from 4155.59 ± 2373.65 BAU/mL to 2389.10 ± 1433.90 BAU/mL, p-value < 0.001 but remained higher than after the second dose (611.92 ± 450.31 BAU/mL). To evaluate the quality of the humoral immune response, we additionally measured neutralizing antibodies, which also showed a small but significant decrease within this short period. These data underline the positive effect of a third dose of BNT162b2 concerning antibody re-induction but also shows a drop of Anti-SARS-CoV-2-IgG within a short span of time.
Open AccessShort-Term Drop in Antibody Titer after the Third Dose of SARS-CoV-2 BNT162b2 Vaccine in Adults
Little is known about the longevity of antibodies after a third dose of the mRNA-based SARS-CoV-2 vaccine BNT162b2 (BioNTech/Pfizer, Mainz, Germany). Therefore, serum antibody levels were evaluated after a third dose of BNT162b2 in healthy adult healthcare workers in Germany. These antibody levels dropped significantly within a short period of 11 weeks from 4155.59 ± 2373.65 BAU/mL to 2389.10 ± 1433.90 BAU/mL, p-value < 0.001 but remained higher than after the second dose (611.92 ± 450.31 BAU/mL). To evaluate the quality of the humoral immune response, we additionally measured neutralizing antibodies, which also showed a small but significant decrease within this short period. These data underline the positive effect of a third dose of BNT162b2 concerning antibody re-induction but also shows a drop of Anti-SARS-CoV-2-IgG within a short span of time.
- Open Access
- 19 October 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (20) , 10972
Half-Year Longitudinal Seroprevalence of SARS-CoV-2-Antibodies and Rule Compliance in German Hospital Employees
COVID-19, which is caused by SARS-CoV-2, is an occupational health risk, especially for healthcare employees due to their higher exposure and consequently higher risk of symptomatic and asymptomatic infections. This study was designed to determine the longitudinal seroprevalence of specific immunoglobulin-G (IgG) antibodies in employees in a hospital setting. All employees in a secondary care hospital, including healthcare and non-healthcare workers, were invited to participate in this single-center study. After an initial screening, a 6-month follow-up was carried out, which included serological examination for SARS-CoV-2 IgG antibodies and a questionnaire for self-reported symptoms, self-perception, and thoughts about local and national hygiene and pandemic plans. The seroprevalence of SARS-CoV-2 IgG antibodies was 0.74% among 406 hospital employees (0.75% in healthcare workers, 0.72% in non-healthcare workers), initially recruited in April 2020, in their follow-up blood specimens in October 2020. In this study, 30.54% of the participants reported using the official German coronavirus mobile application and the majority were content with the local and national rules in relation to coronavirus-related restrictions. At the 6-month follow-up, the 0.74% seroprevalence was below the reported seroprevalence of 1.35% in the general German population. The prevalence in healthcare workers in direct patient care compared with that in workers without direct patient contact did not differ significantly. Further follow-up to monitor the seroprevalence in the high-risk healthcare sector during the ongoing global pandemic is essential.
- 19 October 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (20) , 10972
Open AccessHalf-Year Longitudinal Seroprevalence of SARS-CoV-2-Antibodies and Rule Compliance in German Hospital Employees
COVID-19, which is caused by SARS-CoV-2, is an occupational health risk, especially for healthcare employees due to their higher exposure and consequently higher risk of symptomatic and asymptomatic infections. This study was designed to determine the longitudinal seroprevalence of specific immunoglobulin-G (IgG) antibodies in employees in a hospital setting. All employees in a secondary care hospital, including healthcare and non-healthcare workers, were invited to participate in this single-center study. After an initial screening, a 6-month follow-up was carried out, which included serological examination for SARS-CoV-2 IgG antibodies and a questionnaire for self-reported symptoms, self-perception, and thoughts about local and national hygiene and pandemic plans. The seroprevalence of SARS-CoV-2 IgG antibodies was 0.74% among 406 hospital employees (0.75% in healthcare workers, 0.72% in non-healthcare workers), initially recruited in April 2020, in their follow-up blood specimens in October 2020. In this study, 30.54% of the participants reported using the official German coronavirus mobile application and the majority were content with the local and national rules in relation to coronavirus-related restrictions. At the 6-month follow-up, the 0.74% seroprevalence was below the reported seroprevalence of 1.35% in the general German population. The prevalence in healthcare workers in direct patient care compared with that in workers without direct patient contact did not differ significantly. Further follow-up to monitor the seroprevalence in the high-risk healthcare sector during the ongoing global pandemic is essential.